ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,215Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 247

$1.14M Total Retail Price of All Prescriptions

Rank: 2 out of 247

739 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 739 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 739 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 15,790 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LEVOTHYROXINE SODIUM 860 692 1 3
LOVASTATIN 712 530 2 22
OMEPRAZOLE 669 480 3 4
AMLODIPINE BESYLATE 616 500 4 6
FUROSEMIDE 519 452 5 5
BENAZEPRIL HCL 498 409 6 80
METOPROLOL TARTRATE 474 414 7 7
LISINOPRIL 415 327 8 2
HYDROCHLOROTHIAZIDE 387 323 9 9
DONEPEZIL HCL 387 387 9 35
HYDROCODONE-ACETAMINOPHEN 353 232 S3 11 11
RISPERIDONE 345 324 12 58
CITALOPRAM HBR 337 266 13 20
ATORVASTATIN CALCIUM 333 245 14 8
WARFARIN SODIUM 305 298 15 13
GABAPENTIN 272 206 16 17
NAMENDA 252 252 17 47
ADVAIR DISKUS 251 183 18 18
METFORMIN HCL 223 140 19 12
TRAMADOL HCL 209 157 20 25
PANTOPRAZOLE SODIUM 205 185 21 19
FLUOXETINE HCL 204 147 22 49
LOSARTAN POTASSIUM 203 176 23 15
SERTRALINE HCL 199 157 24 16
METOPROLOL SUCCINATE 199 181 24 14
DOXAZOSIN MESYLATE 196 160 26 57
SPIRIVA 192 135 27 26
TRAZODONE HCL 184 129 28 28
DIOVAN 172 131 29 38
SIMVASTATIN 168 127 30 1
ZOLPIDEM TARTRATE 162 112 31 24
TAMSULOSIN HCL 162 147 31 31
FENTANYL 158 130 S2 33 72
DIVALPROEX SODIUM 154 140 34 117
CRESTOR 146 121 35 30
POTASSIUM CHLORIDE 145 145 36 36
FLUTICASONE PROPIONATE 133 89 37 37
FAMOTIDINE 126 75 38 66
CIPROFLOXACIN HCL 126 98 38 89
GLYBURIDE 124 112 R 40 41
MIRTAZAPINE 122 104 41 46
PROAIR HFA 118 70 42 29
ATENOLOL 117 91 43 10
ALENDRONATE SODIUM 113 106 44 32
ROPINIROLE HCL 108 64 45 69
RANITIDINE HCL 105 87 46 34
CYMBALTA 105 47 46 52
NEXIUM 103 59 48 42
CLOPIDOGREL 103 82 48 70
ISOSORBIDE MONONITRATE ER 102 79 50 40
HALOPERIDOL 101 98 51 175
BUPROPION XL 97 29 52 91
AZITHROMYCIN 94 66 53 48
ESCITALOPRAM OXALATE 94 59 53 65
LANTUS 93 57 55 39
ZETIA 92 67 56 62
PREDNISONE 91 67 57 21
KLOR-CON M20 91 78 57 44
NOVOLOG 90 75 59 99
NYSTOP 86 74 60 133
KLOR-CON M10 85 81 61 95
OXYCODONE-ACETAMINOPHEN 84 55 S2 62 87
KLOR-CON 10 83 74 63 103
PAROXETINE HCL 77 59 64 45
ALLOPURINOL 77 65 64 33
BENICAR 76 67 66 116
VENTOLIN HFA 76 59 66 93
LIPITOR 76 46 66 50
PRAVASTATIN SODIUM 75 59 69 23
ACETAMINOPHEN-CODEINE 72 44 S3 70 159
GLIPIZIDE 71 64 71 43
FENOFIBRATE 69 47 72 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 55 73 138
DOXYCYCLINE HYCLATE 67 53 74 139
BUPROPION HCL SR 66 43 75 115
NOVOLOG MIX 70-30 65 31 76 209
TRIAMCINOLONE ACETONIDE 64 60 77 94
OXYCODONE HCL 64 38 S2 77 27
NOVOLIN 70-30 61 38 79 212
CARVEDILOL 59 39 80 59
CARBIDOPA-LEVODOPA 56 56 81 90
EXELON 56 56 81 102
LIDODERM 55 52 83 74
HYDRALAZINE HCL 53 53 84 99
PEN NEEDLE 53 45 84 79
MECLIZINE HCL 53 52 84 151
PLAVIX 53 43 84 106
NYSTATIN 52 47 88 129
LEVEMIR 50 50 89 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.